RED ONE PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
RED ONE PHARMA
Largest movements
- Receivables within one year +€111,133
up €111,133 (+488.3%), from €22,760 to €133,894
of which Other amounts receivable: +€109,972
- Deferred charges and accrued income -€100,021
down €100,021 (-99.4%), from €100,620 to €599
- Current investments +€60,398
up €60,398 (+108.8%), from €55,535 to €115,933
- Reserves +€473,675
new in 2025: €473,675
- Profit (loss) carried forward -€364,921
down €364,921 (-100.0%), from €364,921 to €0
- Debts after one year -€59,969
down €59,969 (-10.8%), from €557,182 to €497,214
- Financial income -€18,836
down €18,836 (-15.6%), from €121,051 to €102,216
- Gross operating margin -€1,254
down €1,254 (-3.1%), from €40,089 to €38,836
- Other operating charges -€581
down €581 (-16.4%), from €3,534 to €2,954
- Taxes -€412
down €412 (-10.8%), from €3,801 to €3,389
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,136,019 | €1,190,207 | +€54,187 | +4.8% |
| Fixed assets | 21/28 | €934,053 | €925,242 | -€8,811 | -0.9% |
| Tangible fixed assets | 22/27 | €239,721 | €230,910 | -€8,811 | -3.7% |
| Land and buildings | 22 | €239,410 | €230,910 | -€8,500 | -3.6% |
| Furniture and vehicles | 24 | €311 | €0 | -€311 | -100.0% |
| Financial fixed assets | 28 | €694,332 | €694,332 | = | 0.0% |
| Current assets | 29/58 | €201,967 | €264,965 | +€62,998 | +31.2% |
| Amounts receivable within one year | 40/41 | €22,760 | €133,894 | +€111,133 | +488.3% |
| Trade receivables | 40 | - | €1,162 | +€1,162 | |
| Other amounts receivable | 41 | €22,760 | €132,732 | +€109,972 | +483.2% |
| Current investments | 50/53 | €55,535 | €115,933 | +€60,398 | +108.8% |
| Cash at bank and in hand | 54/58 | €23,051 | €14,540 | -€8,511 | -36.9% |
| Deferred charges and accrued income | 490/1 | €100,620 | €599 | -€100,021 | -99.4% |
| Total equity and liabilities | 10/49 | €1,136,019 | €1,190,207 | +€54,187 | +4.8% |
| Equity | 10/15 | €404,921 | €513,675 | +€108,754 | +26.9% |
| Contributions | 10/11 | €40,000 | €40,000 | = | 0.0% |
| Reserves | 13 | - | €473,675 | +€473,675 | |
| Distributable reserves | 133 | - | €473,675 | +€473,675 | |
| Profit (loss) carried forward | 14 | €364,921 | €0 | -€364,921 | -100.0% |
| Amounts payable | 17/49 | €731,098 | €676,532 | -€54,566 | -7.5% |
| Amounts payable after more than one year | 17 | €557,182 | €497,214 | -€59,969 | -10.8% |
| Financial debts | 170/4 | €557,182 | €497,214 | -€59,969 | -10.8% |
| Amounts payable within one year | 42/48 | €173,916 | €177,918 | +€4,002 | +2.3% |
| Current portion of amounts payable after more than one year | 42 | €58,784 | €59,969 | +€1,185 | +2.0% |
| Financial debts | 43 | €2,500 | €3,323 | +€823 | +32.9% |
| Credit institutions | 430/8 | €2,500 | €3,323 | +€823 | +32.9% |
| Trade debts | 44 | €1,064 | €94 | -€970 | -91.2% |
| Suppliers | 440/4 | €1,064 | €94 | -€970 | -91.2% |
| Taxes, remuneration and social security | 45 | €8,031 | €8,307 | +€276 | +3.4% |
| Taxes | 450/3 | €8,031 | €8,307 | +€276 | +3.4% |
| Other amounts payable | 47/48 | €103,536 | €106,225 | +€2,689 | +2.6% |
| Accrued charges and deferred income | 492/3 | - | €1,400 | +€1,400 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €8,963 | €8,811 | -€152 | -1.7% |
| Other operating charges | 640/8 | €3,534 | €2,954 | -€581 | -16.4% |
| Gross operating margin | 9900 | €40,089 | €38,836 | -€1,254 | -3.1% |
| Operating profit (loss) | 9901 | €27,593 | €27,071 | -€522 | -1.9% |
| Financial income | 75/76B | €121,051 | €102,216 | -€18,836 | -15.6% |
| Recurring financial income | 75 | €121,051 | €102,216 | -€18,836 | -15.6% |
| Financial charges | 65/66B | €16,822 | €17,144 | +€323 | +1.9% |
| Recurring financial charges | 65 | €16,822 | €17,144 | +€323 | +1.9% |
| Profit (loss) for the period before taxes | 9903 | €131,822 | €112,142 | -€19,680 | -14.9% |
| Income taxes | 67/77 | €3,801 | €3,389 | -€412 | -10.8% |
| Profit (loss) for the period | 9904 | €128,022 | €108,754 | -€19,268 | -15.1% |
| Profit (loss) for the period to be appropriated | 9905 | €128,022 | €108,754 | -€19,268 | -15.1% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.